CLPTM1 Recombinant Antibody, Biotin Conjugated
Product Specifications
Background
Involved in GABAergic but not glutamatergic transmission. Binds and traps GABAA receptors in the endoplasmic reticulum (ER) . Modulates postsynaptic GABAergic transmission, and therefore inhibitory neurotransmission, by reducing the plasma membrane expression of these receptors. Altered GABAergic signaling is one among many causes of cleft palate.
Synonyms
HS9; N14.
Gene ID
1209
Swiss Prot
O96005
Host
Rabbit
Cross Reactivity
Human
Target
CLPTM1
Clonality
Recombinant
Isotype
IgG
Conjugation
Biotin
Source
KLH conjugated synthetic peptide derived from human Putative lipid scramblase CLPTM1
Applications
WB, IHC-P, IHC-F
Purification
Purified by Protein A.
Concentration
Lot dependent
Dilution
WB (1:300-5000), IHC-P (1:200-400), IHC-F (1:100-500)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C for 12 months.
Gene ID URL
1209
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC472848-100 1x 100 µL
Fibronectin (Fn-3), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040352-100 1x 100 µL
CD31 / PECAM-1 (158-2B3), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC742312-500 1x 500 µL
SOX10 (Melanoma Marker) (rSOX10/1074), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC882424-100 1x 100 µL
BOB.1 (B-Cell Marker) (BOB1/2424), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details